Trademark: GVOKE HYPOPEN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for GVOKE HYPOPEN
We do not have any records of a proof of use for GVOKE HYPOPEN at this moment.
Possible trademark infringements of GVOKE HYPOPEN
Basic Information about GVOKE HYPOPEN
- Serial Number
- 88011932
- Filing Date
- 22 Jun 2018
- Registration Number
- 6136874
- Registration Date
- 25 Aug 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of GVOKE HYPOPEN on the blockchain with WikiTrademarks.io.
- First use of GVOKE HYPOPEN anywhere
- GVOKE HYPOPEN was first used on 29 Jun 2020 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns GVOKE HYPOPEN?
1. Xeris Pharmaceuticals, Inc. Chicago IL
2. Xeris Pharmaceuticals, Inc. Chicago IL
3. Xeris Pharmaceuticals, Inc. Chicago IL
Correspondent
- Tracy-Gene G. Durkin
- Sterne, Kessler, Goldstein & Fox P.L.L.C
- 1100 New York Avenue, NW
- Washington, DC 20005
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io